193 related articles for article (PubMed ID: 9933692)
41. Expression and activity of MMPS and their regulators in ovarian cancer.
Naylor MS; Stamp GW; Davies BD; Balkwill FR
Int J Cancer; 1994 Jul; 58(1):50-6. PubMed ID: 8014015
[TBL] [Abstract][Full Text] [Related]
42. Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas.
Kossakowska AE; Urbanski SJ; Watson A; Hayden LJ; Edwards DR
Oncol Res; 1993; 5(1):19-28. PubMed ID: 8369572
[TBL] [Abstract][Full Text] [Related]
43. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas.
Nakamura H; Ueno H; Yamashita K; Shimada T; Yamamoto E; Noguchi M; Fujimoto N; Sato H; Seiki M; Okada Y
Cancer Res; 1999 Jan; 59(2):467-73. PubMed ID: 9927064
[TBL] [Abstract][Full Text] [Related]
44. Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis.
Sato H; Seiki M
J Biochem; 1996 Feb; 119(2):209-15. PubMed ID: 8882706
[TBL] [Abstract][Full Text] [Related]
45. Expression of membrane-type matrix metalloproteinase 1 (MT1-MMP) in tumor cells enhances pulmonary metastasis in an experimental metastasis assay.
Tsunezuka Y; Kinoh H; Takino T; Watanabe Y; Okada Y; Shinagawa A; Sato H; Seiki M
Cancer Res; 1996 Dec; 56(24):5678-83. PubMed ID: 8971175
[TBL] [Abstract][Full Text] [Related]
46. Activation of tumor cell matrix metalloproteinase-2 by neutrophil proteinases requires expression of membrane-type 1 matrix metalloproteinase.
Schwartz JD; Shamamian P; Monea S; Whiting D; Marcus SG; Galloway AC; Mignatti P
Surgery; 1998 Aug; 124(2):232-8. PubMed ID: 9706143
[TBL] [Abstract][Full Text] [Related]
47. Analysis of MT1-MMP and MMP2 expression in human gastric cancers.
Mori M; Mimori K; Shiraishi T; Fujie T; Baba K; Kusumoto H; Haraguchi M; Ueo H; Akiyoshi T
Int J Cancer; 1997 Jun; 74(3):316-21. PubMed ID: 9221811
[TBL] [Abstract][Full Text] [Related]
48. Increased expression of collagenase-3 (MMP-13) and MT1-MMP in oesophageal cancer is related to cancer aggressiveness.
Etoh T; Inoue H; Yoshikawa Y; Barnard GF; Kitano S; Mori M
Gut; 2000 Jul; 47(1):50-6. PubMed ID: 10861264
[TBL] [Abstract][Full Text] [Related]
49. Expression of tissue inhibitor of metalloproteinase-1 and type IV collagenase/gelatinase messenger RNAs in human breast cancer.
Lindsay CK; Thorgeirsson UP; Tsuda H; Hirohashi S
Hum Pathol; 1997 Mar; 28(3):359-66. PubMed ID: 9042802
[TBL] [Abstract][Full Text] [Related]
50. Gelatinase A (MMP-2) and its mRNA detected in both neoplastic and stromal cells of tumors with different invasive and metastatic properties.
Grigioni WF; D'Errico A; Fiorentino M; Baccarini P; Onisto M; Caenazzo C; Stetler-Stevenson WG; Garbisa S; Mancini AM
Diagn Mol Pathol; 1994 Sep; 3(3):163-9. PubMed ID: 7981891
[TBL] [Abstract][Full Text] [Related]
51. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
[TBL] [Abstract][Full Text] [Related]
52. Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer.
Gress TM; Müller-Pillasch F; Lerch MM; Friess H; Büchler M; Adler G
Int J Cancer; 1995 Aug; 62(4):407-13. PubMed ID: 7635566
[TBL] [Abstract][Full Text] [Related]
53. mRNA levels of membrane-type 1 matrix metalloproteinase (MT1-MMP), MMP-2, and MMP-9 and of their inhibitors TIMP-2 and TIMP-3 in normal thyrocytes and thyroid carcinoma cell lines.
Hofmann A; Laue S; Rost AK; Scherbaum WA; Aust G
Thyroid; 1998 Mar; 8(3):203-14. PubMed ID: 9545106
[TBL] [Abstract][Full Text] [Related]
54. Role of the matrix metalloproteinase and tissue inhibitors of metalloproteinase families in noninvasive and invasive tumors transplanted in mice with severe combined immunodeficiency.
Furukawa A; Tsuji M; Nishitani M; Kanda K; Inoue Y; Kanayama H; Kagawa S
Urology; 1998 May; 51(5):849-53. PubMed ID: 9610608
[TBL] [Abstract][Full Text] [Related]
55. Differential expression of MT1-MMP (MMP-14) and collagenase III (MMP-13) genes in normal and wounded rat corneas.
Ye HQ; Maeda M; Yu FS; Azar DT
Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):2894-9. PubMed ID: 10967042
[TBL] [Abstract][Full Text] [Related]
56. Inhibition of matrix metalloproteinase-14 in osteosarcoma cells by clodronate.
Heikkilä P; Teronen O; Hirn MY; Sorsa T; Tervahartiala T; Salo T; Konttinen YT; Halttunen T; Moilanen M; Hanemaaijer R; Laitinen M
J Surg Res; 2003 May; 111(1):45-52. PubMed ID: 12842447
[TBL] [Abstract][Full Text] [Related]
57. Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas.
Airola K; Karonen T; Vaalamo M; Lehti K; Lohi J; Kariniemi AL; Keski-Oja J; Saarialho-Kere UK
Br J Cancer; 1999 May; 80(5-6):733-43. PubMed ID: 10360651
[TBL] [Abstract][Full Text] [Related]
58. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
59. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis.
Kossakowska AE; Edwards DR; Lee SS; Urbanski LS; Stabbler AL; Zhang CL; Phillips BW; Zhang Y; Urbanski SJ
Am J Pathol; 1998 Dec; 153(6):1895-902. PubMed ID: 9846979
[TBL] [Abstract][Full Text] [Related]
60. Differential expression of matrix metalloproteinases in activated c-ras-Ha-transfected immortalized human keratinocytes.
Meade-Tollin LC; Boukamp P; Fusenig NE; Bowen CP; Tsang TC; Bowden GT
Br J Cancer; 1998 Mar; 77(5):724-30. PubMed ID: 9514050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]